100 Mg 4 Ml Bevacizumab Injection

Name: 100 Mg 4 Ml Bevacizumab Injection
Brand: NEETCO BIOPHARMA
Price: 8000 INR
Availability: InStock

Price 8000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

100 Mg 4 Ml Bevacizumab Injection Specification

Dosage Form
Injection

Salt Composition
Bevacizumab 100 mg/4 ml

Indication
Used in treatment of metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma and certain other cancers

Enzyme Types
Not applicable (monoclonal antibody)

Feature
Anticancer, recombinant humanized monoclonal antibody

Ingredients
Bevacizumab, excipients and sterile water for injection

Application
Intravenous use only, as prescribed by oncologist

Ph Level
6.2

Physical Color/Texture
Clear to slightly opalescent, colorless to pale brown liquid

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Shelf Life
24 months

Contraindications
Known hypersensitivity to Bevacizumab, pregnancy and lactation, severe uncontrolled hypertension

Administration Route
Intravenous infusion

Packaging Size
Single vial of 4 ml

Use In Pediatrics
Use with caution; safety not established

Manufactured By
As per label (varies with supplier)

Marketed Form
Liquid solution for injection

Dilution
To be diluted with 0.9% Sodium Chloride solution before administration

Strength
100 mg/4 ml (25 mg/ml)

Prescription/Non Prescription
Prescription only

Therapeutic Class
Monoclonal antibody, Antineoplastic agent

Packaging Type
Vial

Precautions
Monitor blood pressure, proteinuria, and signs of bleeding during treatment

About 100 Mg 4 Ml Bevacizumab Injection

Procure the paragon of anticancer therapies with the 100 Mg 4 Ml Bevacizumab Injection, an exquisite and rarefied monoclonal antibody formulated for intravenous infusion. Sourced only through prescription, this single vial contains 100 mg/4 ml (25 mg/ml) of Bevacizumab, intended for treatment of metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and more. Find this anticancer solution ending soon in stock at select distributors, exporters, and traders across India. Monitor precautions closely; dilution with 0.9% Sodium Chloride solution is mandatory before use.

Diverse Therapeutic Applications

100 Mg 4 Ml Bevacizumab Injection is used for intravenous administration in oncology settings. Its application areas span metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and renal cell carcinoma. This liquid solution is administered only by a specialized oncologist, ensuring its rarefied efficacy reaches the right surface: the vascular system. Designed for single-use vials, Bevacizumab supports targeted cancer therapy in both hospital and clinical settings.

Prompt Delivery & Global Reach

Estimate delivery times based on client location and regulatory protocols, with swift packing & dispatch processes ensuring product integrity. Main export markets include regions across Asia, Europe, and Africa, where reliable supply abilities meet growing oncology needs. Bevacizumab Injection is diligently dispatched under temperature-controlled environments to preserve potency. The supply is regularly monitored to fulfill demands in distributor, exporter, and trader channels throughout India.

FAQ's of 100 Mg 4 Ml Bevacizumab Injection:

Q: How should the 100 Mg 4 Ml Bevacizumab Injection be administered for optimal efficacy?

A: The injection is given via intravenous infusion following dilution with 0.9% Sodium Chloride solution. Administration must be performed by a qualified medical professional, typically an oncologist.

Q: What are the indications for using Bevacizumab Injection?

A: Bevacizumab is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and renal cell carcinoma, among select other malignancies.

Q: When should Bevacizumab Injection not be used?

A: The injection is contraindicated in individuals with known hypersensitivity to Bevacizumab, pregnancy or lactation, and those with severe uncontrolled hypertension.

Q: Where can distributors and healthcare providers procure this rarefied injection?

A: Distributors, exporters, suppliers, and hospital pharmacy traders in India can order the product directly, subject to prescription and regulatory clearance.

Q: What precautions must be observed during treatment with Bevacizumab?

A: Blood pressure should be monitored, along with checks for proteinuria and signs of bleeding, in order to promptly address potential adverse effects during therapy.